Search by Drug Name or NDC
NDC 14537-0820-03 Anticoagulant Citrate Dextrose (ACD-A) .08; .245; .22 g/10mL; g/10mL; g/10mL Details
Anticoagulant Citrate Dextrose (ACD-A) .08; .245; .22 g/10mL; g/10mL; g/10mL
Anticoagulant Citrate Dextrose (ACD-A) is a INTRAVENOUS SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Terumo BCT, Ltd. The primary component is CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM.
Product Information
NDC | 14537-0820 |
---|---|
Product ID | 14537-820_45c01c61-c4a0-4b2f-9848-964a3fbd9615 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Anticoagulant Citrate Dextrose (ACD-A) |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Dextrose Monohydrate, sodium citrate, unspecified form, and Citric Acid Monohydrate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | .08; .245; .22 |
Active Ingredient Units | g/10mL; g/10mL; g/10mL |
Substance Name | CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM |
Labeler Name | Terumo BCT, Ltd |
Pharmaceutical Class | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorpti |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | BA110057 |
Listing Certified Through | 2024-12-31 |
Package
NDC 14537-0820-03 (14537082003)
NDC Package Code | 14537-820-03 |
---|---|
Billing NDC | 14537082003 |
Package | 50 POUCH in 1 CASE (14537-820-03) / 1 BAG in 1 POUCH (14537-820-01) / 50 mL in 1 BAG (14537-820-00) |
Marketing Start Date | 2023-07-18 |
NDC Exclude Flag | N |
Pricing Information | N/A |